ABSTRACT
INTRODUCTION
The onset, progression and management of type 2 diabetes mellitus remain a major challenge.
Given the many accompanying complications and comorbidities of diabetes, a comprehensive understanding of all factors underpinning its development and progression is absolutely essential. A profusion of literature surrounds the role of sleep and type 2 diabetes. Sleep is a significant and modifiable lifestyle behavior.
Understanding the relationship between sleep and diabetes mellitus is crucial and will enable the development of strategies to improve the life of those with diabetes.
Sleep is regulated by two interconnected processes, named Process S (homeostatic drive) and Process C (circadian drive) [1] . 
Compliance with Ethics Guidelines
This article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors.
Study Selection Criteria
Our review focused on the literature surrounding multiple sleep features and the relationship with measures/indicators of type 2 diabetes mellitus. Specifically, we reviewed the literature for human, adult (C18 years)
populations and excluded animal studies or studies not published in the English language.
We selected studies using a comprehensive search of the electronic databases, PubMed and MEDLINE. The search terms entered into these electronic databases in May 2015 included: type 2 diabetes mellitus, insulin resistance, insulin sensitivity, glycemic control, glucose control and sleep duration, sleep quality, circadian misalignment, circadian preference, chronotype and napping. The search highlighted a total of 83 studies of which there were 6 case-control, 41 cross-sectional, 15 prospective cohort and 21 experimental studies.
Sleep Quantity, Insulin Resistance and Diabetes
Sleep curtailment is now widespread, usually to accommodate busy lifestyles within contemporary society, mirroring the increases in global diabetes mellitus [2] . The use of modern technology is also increasingly family history) were not included in the analyses [3] . Further evidence has resulted from a small number of case-control studies that are highlighted in Table 2 .
Cross-Sectional Studies
The cross-sectional evidence linking sleep duration to T2DM has continued to accumulate (Table 3) . The majority of studies have indicated an increased possibility of various diabetes outcomes with differing definitions of short sleep duration [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] .
Understanding pre-diabetes provides a key insight into the development of T2DM.
Chaput and colleagues performed an oral glucose tolerance test in 740 participants, aged 21-64 years without a known diabetes diagnosis. Sleep duration (h) was self-reported from only one question, inserted into a self-administered physical activity questionnaire. After adjustment for major confounders such as physical activity and energy intake (self-reported) along with age, marital and employment status, education, (Table 3 ) and prospective studies provide key evidence for unraveling this and clarifying temporal associations.
Prospective Studies
A summary of prospective studies that have examined the sleep-diabetes relationship can be found in Table 4 . The Niigata Wellness Study, which prospectively studied 38,987 Japanese participants without diabetes over an 8-year period, found that younger individuals (\60 years old) who reported sleeping \5.5 h per night had a 53% significant increased risk of developing diabetes compared to those that slept for 7-7.5 h per night, after adjustment [20] . Gangwisch and colleagues reported a similar significant risk for incident diabetes with short sleep. Participants, aged 32-86 years (n = 8992), recruited into the National Health and Nutrition Examination Survey were examined over a 10-year period. Short sleep duration was defined as B5 h and was associated with 1.47 increased odds of incident diabetes [21] . Other prospective data suggest similar effect sizes but vary according to adjustment of confounders and short sleep duration definition [22, 23] . The prospective evidence is, however, less consistent with some reporting a diminished relationship after adjustment for 
Sleep Quality in Relation to Insulin Resistance and Diabetes
Severely short sleep, defined by some as B5 h per night, as well as insomnia has been previously linked to a significantly increased risk of T2DM [18] and increased insulin resistance [39] through validated sleep measures. Lack of self-reported sleep [40] as well as sleep debt [41] has also been linked to the condition. These sleep outcomes (insomnia, lack of sleep and sleep debt) may be due to poor-quality sleep, which has resulted in researchers investigating this in relation to diabetes.
The most commonly used validated sleep quality questionnaire is the Pittsburgh Sleep Quality Index (PSQI). It is 24-item survey with 7 subcategories (sleep duration, disturbance, medication, latency, quality and efficiency as well as daytime dysfunction) that can be totaled to provide an overall score [42] . A combined score of more than five is suggestive of poor sleep quality. Some have investigated the prevalence of sleep quality, as determined by the PSQI, among T2DM. Fiorentini and colleagues reported a higher prevalence of T2DM in those with poor-quality sleep (19.4%) compared to those with good quality sleep (8.8%) [43] . Similarly, another study reported 33.3% of 50 participants with an HbA1c level of [7% had poor quality sleep [44] . Another reported 55% of 300 T2DM patients had poor-quality sleep [45] . Further, a sample of 551 patients in China revealed that the prevalence of poor sleep quality was significantly greater in those with poorer glycemic control and that average insulin resistance was higher among those with poorer sleep quality [16] . A larger effect size was observed by Tsai et al. using HbA1c levels to compare sleep quality using the PSQI [46] . After adjustment for age, gender and BMI in a sample of 46 T2DM patients, poor sleep quality was associated with poorer glycemic control OR 6.94, p = 0.002 [46] . Small studies with subjective sleep quality measures may be the result of chronic complications or 'side effects' of T2DM. In an attempt to disentangle the chronic impact of diabetes on sleep, Rajendran and colleagues administered the PSQI to investigate the relationship between sleep quality and duration of T2DM in 120 patients. Diabetes duration was negatively associated with the global PSQI score (b = -020, p = 0.02), independent of age, gender, BMI, HbA1c and medication [47] . This association is consistent with another larger study (n = 614 older patients with T2DM) [48] .
Aside from the existing data from diabetic populations, the relationship between sleep quality and insulin resistance has also been investigated in healthy individuals as well as Comparing all groups to the healthy group, only those with an existing diagnosis of T2DM showed a significant effect of poor sleep quality, OR 2.27 (95% CI 1.39-3.70), after adjustment [49] . Although cross sectional, this study partly controls for the potential chronic and psychological impact of diabetes on sleep given that those with diabetes were unaware of their diagnosis. 
The Emerging Effect of Sleep-Wake Misalignment Upon Insulin Resistance and Diabetes
While the majority of focus has been on sleep quantity and quality relative to diabetes, there is now emerging evidence suggesting that circadian rhythms, chronotype and sleep-wake timings play an important role in diabetes onset, development and management. It is well established that shift workers have a higher prevalence of metabolic disorders [60] .
In particular, night-shift workers and rotating shift workers are among those worst affected as they not only experience circadian disruption but also sleep loss. These extreme patterns are in conflict with human evolution and challenge our internal circadian pacemakers, regulated by the hypothalamic suprachiasmatic nucleus. Recent evidence suggests that extreme sleep-wake timings are not necessary to cause metabolic alteration, but that even slightly shifted changes and/or circadian preferences can influence diabetes.
Buxton and colleagues examined the effects of sleep restriction combined with gradual circadian misalignment (eventually simulating shift-work patterns) upon glucose metabolism.
A total of 21 healthy participants were examined across a 39 consecutive day/night period in a strictly controlled laboratory setting [61] . A 32% reduction in insulin response to a standardized meal was reported, resulting in inadequate glucose regulation. The resting metabolic rate was also reduced following indicate evening types, suggesting that 'night owls' had poorer glycemic control [65] . Another study included 725 Japanese mixed-gender T2DM patients and found a dose-dependent effect of circadian preference on HbA1c levels.
HbA1c was significantly higher in those with evening preference (7.3%) compared to morning types (6.7%), and linear regression revealed b = -2.94, p\0.01 after adjustment for a range of established potential confounders including physical activity, dietary intake and demographics [64] . One further study that recruited a random sample of 6,258 Finnish adults, aged 25-74 years, revealed that evening types (determined from MEQ) predicted increased odds of T2DM (OR 2.6, p\0.0001), after adjustment [12] . Two more studies by the same group, and possibly data analysis from the same sample, demonstrated significant evening chronotype associations with diabetes [62, 63] .
A total of 194 T2DM patients were assessed using the midpoint of sleep, calculated from self-reported estimated sleep-wake times in order to determine circadian preference (chronotype). Glycemic control (HbA1c) was obtained from medical records, and the relationship was assessed with circadian preference. The midpoint of sleep on free days was positively correlated (r = 0.34, p\0.001) with glycemic control. In hierarchial regression analysis, the association remained, where b = 0.03, p = 0.001 after adjustment [63] . Similar findings were reported in the other study where it was proposed that chronotype mediated the association between skipping breakfast and glycemic control [62] . [73] .
Snoring may also be a risk factor for T2DM [74] , possibly as a consequence of OSA.
Undoubtedly, OSA is strongly linked to diabetes, although which develops first is to be determined, given that they are both noncommunicable. Obstructive sleep apnea (OSA), as well as concomitant intermittent nocturnal hypoxemia, is common in patients with T2DM [75, 76] . Several studies have reported an association between OSA, glycemic control and diabetes microvascular complications [77] [78] [79] [80] [81] . OSA appears to be more common in ethnicities where T2DM is more common [82] . Many studies have not been able to address the confounding effect of OSA in the relationship between sleep and metabolism. Interestingly, continuous positive airway pressure (CPAP), used to treat OSA, has also been shown to improve glycemic control prospectively [75] . Thus, improving sleep can in turn improve metabolic profiles. While SDB certainly disrupts metabolic regulation and extensive data have recently emerged in relation to insulin resistance and other features of diabetes, this is beyond the scope of the current review. Clearly, the extent of other sleep aspects on metabolic health is slowly emerging, although a better understanding of all characteristics is still required, along with mechanistic explanations.
Significant changes in sleep architecture have also been noted in a retrospective case-control study [58] . T2DM patients had 4.5% less slow wave sleep (SWS) and 10.3% more rapid eye movement (REM) sleep compared to those without the condition. Differences in sleep architecture between those with and without diabetes have also been investigated in the Sleep Heart Healthy Study but detected different results [83] . Differences in SWS between diabetic and non-diabetic volunteers diminished after adjustment, and REM sleep accounted for a significantly reduced proportion of total sleep time in those with diabetes [83] . Tasali and colleagues attempted to disentangle this relationship by suppressing SWS for 3 consecutive nights using an acoustic stimulus in nine healthy, young volunteers [84] . SWS suppression was achieved and resulted in significant reductions in insulin sensitivity (*25%) and glucose tolerance (*23%) compared to baseline. SWS is considered to have a restorative effect; thus, a reduction in this deep phase of sleep may induce metabolic alterations that can promote diabetes as well as other related comorbidities.
SWS declines with age and diabetes risk increases with age; thus, age may mediate this relationship, and future studies need to investigate the strength of such associations in older individuals as well as those with T2DM.
Mechanisms
There is now clear evidence linking sleep to the onset and development of pre-diabetes and T2DM.
Understanding the mechanisms involved is of great importance. It has been suggested that insufficient sleep and/or poor quality sleep can result in oxidative stress as well as overactivation of the sympathetic nervous system, and some have used heart rate variability to support this notion [31] . Others have shown that changes in the appetite-regulating hormones leptin (related to satiety) and ghrelin (related to hunger) have been observed in response to short/insufficient sleep duration [85, 86] . Disruption of the regulation of these hormones from sleep loss has also been linked to an increased appetite for carbohydrate-dense foods [85, 86] and intake of calories from sweet foods (snacks) [87] . Poor dietary habits are well known to promote T2DM; thus, the effects of sleep loss may contribute to these unhealthy behaviors through metabolic disruption. Sleep deprivation is associated with activation of the hypothalamic orexin (hypocretin) neuropeptide system [88] [89] [90] . Orexin [91, 92] . The precise site of action of bromocriptine in regulating metabolism is unknown, but dopamine acts at several levels including the hypothalamus and pineal gland [93] , which are key areas for the regulation of circadian rhythms, sleep and metabolism. The timing of bromocriptine administration in glycemic regulation appears to be important with greater effects in the morning when endogenous dopaminergic drive is at its peak. A side effect of bromocriptine for diabetes treatment is sleepiness. Dopamine receptor antagonism by anti-psychotic drugs has been observed to be associated with obesity and subsequent insulin resistance and diabetes.
Key Limitations
Some observational data highlight a U-shaped relationship between sleep and diabetes prevalence, and while much of the focus has been on short sleepers, long sleep may also be problematic and has shown a greater effect size compared to short sleep in a recent meta-analysis of prospective studies [94] . criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published.
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